These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26286466)

  • 1. Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.
    Gadotti VM; Bladen C; Zhang FX; Chen L; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
    Pflugers Arch; 2015 Dec; 467(12):2485-93. PubMed ID: 26286466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
    Bladen C; Gadotti VM; Gündüz MG; Berger ND; Şimşek R; Şafak C; Zamponi GW
    Pflugers Arch; 2015 Jun; 467(6):1237-47. PubMed ID: 24990197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain.
    Yamamoto S; Suzuki Y; Ono H; Kume K; Ohsawa M
    Eur J Pharmacol; 2016 Dec; 793():66-75. PubMed ID: 27823932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain.
    Antunes FTT; Huang S; Chen L; Zamponi GW
    Eur J Pharmacol; 2024 Mar; 967():176416. PubMed ID: 38342359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain.
    M'Dahoma S; Gadotti VM; Zhang FX; Park B; Nam JH; Onnis V; Balboni G; Lee JY; Zamponi GW
    Pflugers Arch; 2016 Feb; 468(2):193-9. PubMed ID: 26354962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
    Pudukulatham Z; Zhang FX; Gadotti VM; M'Dahoma S; Swami P; Tamboli Y; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27053601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.
    Bladen C; McDaniel SW; Gadotti VM; Petrov RR; Berger ND; Diaz P; Zamponi GW
    ACS Chem Neurosci; 2015 Feb; 6(2):277-87. PubMed ID: 25314588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
    Drígelová M; Tarabová B; Duburs G; Lacinová L
    Can J Physiol Pharmacol; 2009 Nov; 87(11):923-32. PubMed ID: 19935900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
    Berger ND; Gadotti VM; Petrov RR; Chapman K; Diaz P; Zamponi GW
    Mol Pain; 2014 Dec; 10():77. PubMed ID: 25481027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
    Barbara G; Alloui A; Nargeot J; Lory P; Eschalier A; Bourinet E; Chemin J
    J Neurosci; 2009 Oct; 29(42):13106-14. PubMed ID: 19846698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
    Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
    Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.
    Rivas-Ramirez P; Gadotti VM; Zamponi GW; Weiss N
    Pflugers Arch; 2017 Oct; 469(10):1325-1334. PubMed ID: 28664409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
    Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
    Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels.
    Shan Z; Cai S; Yu J; Zhang Z; Vallecillo TGM; Serafini MJ; Thomas AM; Pham NYN; Bellampalli SS; Moutal A; Zhou Y; Xu GB; Xu YM; Luo S; Patek M; Streicher JM; Gunatilaka AAL; Khanna R
    ACS Chem Neurosci; 2019 Jun; 10(6):2939-2955. PubMed ID: 30946560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icilin reduces voltage-gated calcium channel currents in naïve and injured DRG neurons in the rat spinal nerve ligation model.
    Hagenacker T; Lampe M; Schäfers M
    Brain Res; 2014 Apr; 1557():171-9. PubMed ID: 24560602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.